Trial · NCT00051532
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
NCT00051532, Not applicable, Terminated, LEO Pharma
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma. Trials, record NCT00051532. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00051532
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
- NCT number
- NCT00051532
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 700 participants
- Lead sponsor
- LEO Pharma
- Conditions
- Liver Neoplasms
- Interventions
- Seocalcitol
- First posted
- 2003-01-14
- Last updated
- 2025-02-25
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Overall survival, defined as the time from start of treatment to death | ||
| Secondary | HCC-specific survival from start of treatment | ||
| Secondary | Time to response from start of treatment (complete or partial response) | ||
| Secondary | Proportion of patients who achieve partial/complete response | ||
| Secondary | Time to progression measured from start of treatment | ||
| Secondary | Duration of complete response in patients showing a complete response, measured from the first date when absence of disease was recorded until the first date of disease progression was recorded | ||
| Secondary | Duration of partial response in patients showing partial response, measured from first date when partial response was recorded until the first date at which disease progression was observed | ||
| Secondary | Duration of stable disease measured from start of treatment until the first date where either progression or partial/complete response was observed | ||
| Secondary | Change(s) in tumour size | ||
| Secondary | Change in tumour marker |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00051532
GET https://conductscience.org/api/trials/v1/NCT00051532/registered